RLHC Opens Franchise in Fort Collins, Colorado
GlobeNewswire - Tue Dec 23, 3:06PM CST
RLHC (Red Lion Hotels Corporation, NYSE: RLH) announced the company opened a new franchise location in Colorado. This is the second location this owner has franchised with the company.
RLH: 6.04 (+0.01), A: 41.13 (-0.24)
Global Food Safety Testing Market Outlook 2019
M2 - Mon Dec 22, 8:14AM CST
Research and Markets (http://www.researchandmarkets.com/research/v4kvpv/global_food) has announced the addition of the "Global Food Safety Testing Market Outlook 2019" report to their offering. The problem of food affected by several contaminants is getting increasingly relevant worldwide, raising concerns for food safety testing. In today's world, the scope, relevance, and level of food safety regulation and testing have reached a high level. The worldwide rise in cases of food contamination and increased consumer awareness has generated a lot of hype around food diagnostics, transforming it into a significant public health issue. Therefore, it has become inevitable for manufacturers to seek more advanced, comprehensive, technical, yet flexible approaches to ensure the safety of their products. In the latest research report Global Food Safety Testing Market Outlook 2019, our analysts have studied the global food safety testing market in terms of contaminants and key markets. The report covers a detailed analysis of the global food safety testing market, which has been segmented into contaminants and other key markets. The food safety testing market by contaminants (pathogen, pesticides, toxins and GMO) and by food type has been forecasted till 2019. A detailed description has also been provided for the food safety market by technology for traditional testing and rapid testing (like PCR, Chromatography and ELISA). In addition, we have provided the market forecasts of the global food safety testing market for countries such as US, China and Europe till 2019. Increasing government regulations and stringent policies, which countries across the world have formulated, have resulted in stringent food safety regulations and testing methods in these countries. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. Industry Trends and Drivers 4. Global Food Safety Testing Market Outlook to 2019 5. Regulatory Environment 6. Competitive Landscape Companies Mentioned: - 3M - Agilent Technologies - BioMerieux SA - BioRad - Bureau Veritas - DuPont - Eurofins - Intertek - SGS SA - Thermo Fisher Scientific Inc For more information visit http://www.researchandmarkets.com/research/v4...lobal_food
A: 41.13 (-0.24)
Metabolomics - 2014 Global Strategic Business Report
M2 - Thu Dec 18, 3:02AM CST
Research and Markets (http://www.researchandmarkets.com/research/4k93mv/metabolomics) has announced the addition of the "Metabolomics - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Metabolomics in US$ Million by the following Product Segments: - Bioinformatics Tools in Metabolomic Research - Bioanalytical Instruments and Equipment - Metabolomics Applications The report profiles 34 companies including many key and niche players such as: - AB SCIEX - Agilent Technologies, Inc. - Biocrates Life Sciences AG - Bio-Rad Laboratories, Inc. - Bruker Corporation Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. An Insight Into Metabolomics Applications 3. An Insight Into Select Separation And Detection Technologies 4. Product Overview 5. Product Introductions/Innovations 6. Recent Industry Activity 7. Focus On Select Players 8. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 34 (including Divisions/Subsidiaries 37) - The United States (22) - Canada (2) - Japan (4) - Europe (
A: 41.13 (-0.24)
Research and Markets: Global Wireless Test Equipment Market 2015-2019 with Aeroflex Holding, Agilent Technologies, Anritsu, Ixia, JDS Uniphase & Spirent Communications Dominating
Business Wire - Wed Dec 17, 8:50AM CST
Research and Markets (http://www.researchandmarkets.com/research/gl5mvc/global_wireless) has announced the addition of the "Global Wireless Test Equipment Market 2015-2019" report to their offering.
ARX: 10.50 (unch), A: 41.13 (-0.24), JDSU: 14.01 (+0.13)
Global Wireless Test Equipment Market 2015-2019 with Aeroflex Holding, Agilent Technologies, Anritsu, Ixia, JDS Uniphase & Spirent Communications Dominating
M2 - Wed Dec 17, 5:14AM CST
Research and Markets (http://www.researchandmarkets.com/research/9d4hcc/global_wireless) has announced the addition of the "Global Wireless Test Equipment Market 2015-2019" report to their offering. The Global Wireless Test Equipment market to grow at a CAGR of 7.25% over the period 2014-2019 Wireless networks are made of many components including base units, antennas, radio, and cables. These components have functionalities that need to be tested for efficiency before they are deployed in wireless networks. The testing of these components and features is carried out using wireless test equipment, which is widely used to ensure proper network deployment and efficient working of wireless networks. With the increased adoption of 4G networks, and growing popularity of LTE technology, the demand for wireless testing equipment has increased significantly over the past few years. Wireless testing helps service providers to provide efficient and error-free networks. One of the major trends in the market is the inter-operability of technologies. Wireless test equipment is devised to maintain the inter-operability of technologies, which is expected to drive the market for test equipment in the future. According to the report, one of the main drivers of the market is the increased adoption of smart devices. People around the world have moved toward using smart devices such as smartphones, smart watches, and iPads, which integrate voice, video, and data transfer in a single device. Further, the report states that one of the main challenges in the market is the need for high investment. Changing technologies have made companies invest more to keep up with demand and specific customization based on requirements, thus increasing costs. The Global Wireless Test Equipment market can be segmented into three segments: - WCDMA - Other RF Technologies - LTE - Other New Technologies Key Vendors - Aeroflex Holding - Agilent Technologies - Anritsu - Ixia - JDS Uniphase - Spirent Communications Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Technology - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/9d...l_wireless
ARX: 10.50 (unch), A: 41.13 (-0.24), JDSU: 14.01 (+0.13), XXIA: 10.80 (-0.10)
Global Digital PCR Market Report 2013-2020: PCR Reaction, Target DNA, PCR Based Diagnostics & SNP Detection Analysis of the $6.5 Billion Industry
M2 - Mon Dec 15, 5:11AM CST
Research and Markets (http://www.researchandmarkets.com/research/8zs45s/digital_pcr) has announced the addition of the "Digital PCR market research PCR reaction market, target DNA market, PCR based diagnostics market, SNP detection market 2013 - 2020" report to their offering. The polymerase chain reaction (PCR) technologies market reached over $6.5 billion at the end of 2013 PCR enables quantification and detection of target DNA. PCR is a valuable tool in diagnosis, clinical trials and drug discovery. PCR application in critical research areas such as gene expression analysis, genotyping, viral quantification, HIV DNA detection and quantification etc. have provided valuable data to the field of medical science. Quantitative real-time PCR (qPCR) is being used largely by bio-pharma and academic labs. However, digital PCR (dPCR) are gaining focus currently. FDA approvals for clinical diagnosis and drugs depend on the clarity and consistency of results. For example qPCR based tests may have issues withrespect to amplification efficiency that could vary with PCR primers and type of patient. Therefore, in such cases dPCR produces results that are more consistent. dPCR provide higher level of precision and greater sensitivity. This can directly affect the time span of FDA approvals. Key Topics Covered: 1. PCR Basics 2. Key Components of PCR - Instrumentation, Services, Reagents and Media etc: A Snap Shot 3. qPCR Verusus 4. Regulations 5. Conventional PCR, qPCR Versus dPCR 6. Key Application Areas of PCR Technology 7. Key Motivators for Adoption of dPCR 8. Key Restraints for Adoption of dPCR 9. Opportunity Analysis 10. Value Chain Analysis Across Stakeholders (Instrument Manufacturers, Reagent Providers, Services etc) 11. Key Buying Criteria 12. Strategic Recommendations 13. Competitive Intelligence 14. dPCR Market by Components ($Million), 2013 to 2018 15. dPCR Market by Applications ($Million), 2013 to 2018 16. Geographic Analysis 17. Corporate Profiling - Roche - Bio-Rad - Life Technologies (Applied Biosystems and Invitrogen) - Qiagen - Promega - Agilent Technologies - Thermo Fisher Scientific - Sigma-Aldrich For more information visit http://www.researchandmarkets.com/research/8z...igital_pcr
A: 41.13 (-0.24)
RLHC Signs Franchise in Colorado and Opens New Franchise at Detroit Airport
GlobeNewswire - Wed Dec 10, 8:04AM CST
RLHC (Red Lion Hotels Corporation NYSE:RLH) announced the company signed a franchise agreement for a new location in Colorado and also opened a new franchise location near the Detroit Airport.
RLH: 6.04 (+0.01), A: 41.13 (-0.24)
Research and Markets: Global Cellular Imaging Markets Report 2014
Business Wire - Wed Dec 10, 3:08AM CST
Research and Markets (http://www.researchandmarkets.com/research/r8ggbl/cellular_imaging) has announced the addition of the "Global Cellular Imaging Markets Report 2014" report to their offering.
A: 41.13 (-0.24), SIAL: 137.16 (-0.01), DHR: 86.79 (-0.27)
Global Cellular Imaging Markets Report 2014
M2 - Wed Dec 10, 2:56AM CST
Research and Markets (http://www.researchandmarkets.com/research/tj5773/cellular_imaging) has announced the addition of the "Global Cellular Imaging Markets Report 2014" report to their offering. The Global Cellular Imaging Market is dominated by Beckton Dickinson and Company, Danaher Corporation, Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., GE Healthcare, Merck KGAA, Olympus Corpopration, Perkinelmer, Inc., Promega Corporation. The global cell analysis market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Most of the players in the cell analysis instruments market are collaborating with companies and educational institutes in order to offer the products with better software also. The cell analysis market is expected to grow steadily in the forecast period. The major factor driving the growth is improved accuracy of cell imaging and analysis systems which in turn reduce time and cost of drug discovery process. In addition, the factors like increasing prevalence of cancer, getting help from the government bodies in the form of investments, funds and grants, improved informatics services, availability of better reagents and image analysis instruments are propelling the growth of the market. However, the major market restraints include enormous capital investments and shortage of skilled labor for high content screening procedure. The biggest opportunities for this market is the growing APAC market, high content screening services provided by CRO's, automation in cancer research for its early detection and reducing cost of the cancer treatment. Key Topics Covered: 1. Executive summary 2. Introduction 3. Market Analysis 4. Single cell analysis market by technology 5. Single cell analysis market by products 6. Single cell analysis market by field of study 7. Single cell analysis market by applications 8. Single cell analysis market by end users 9. Regional Market Analysis 10. Company Developments 11. Major Company Profiles - Agilent Technologies, Inc. - Beckton, Dickinson And Company - Danaher Corporation - GE Healthcare - Merck KGaA - Olympus Corpopration - Perkinelmer, Inc - Promega Corporation - Sigma-Aldrich Corporation - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/tj...ar_imaging
A: 41.13 (-0.24), SIAL: 137.16 (-0.01), DHR: 86.79 (-0.27)
2014-2018 US Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers
M2 - Mon Dec 08, 8:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/vf9r39/20142018_us) has announced the addition of the "2014-2018 US Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers" report to their offering. This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Caliper - Cepheid - Decode - Diadexus - Eiken - Enzo - Exact Sciences - Grifols - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Proteome Sciences - Qiagen - Roche - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/vf...0142018_us
MYGN: 36.50 (+0.28), A: 41.13 (-0.24), CPHD: 53.39 (+0.51), DHR: 86.79 (-0.27)
Life Sciences Tools and Services Equities Coverage - Agilent Technologies, Thermo Fisher Scientific, Bruker, Quintiles Transnational, and Covance
PR Newswire - Mon Dec 08, 8:05AM CST
Investor-Edge has initiated coverage on the following equities: Agilent Technologies Inc. (NYSE: A), Thermo Fisher Scientific Inc. (NYSE: TMO), Bruker Corporation (NASDAQ: BRKR), Quintiles Transnational Holdings Inc. (NYSE: Q), and Covance Inc. (NYSE: CVD). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Friday, December 05, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,958.79, up 0.33% and the NASDAQ Composite closed at 4,780.76, up 0.24%. The S&P 500 finished the session 0.17% higher at 2,075.37. During the trading session, five out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 817.34, up 0.77%, with the index advancing 10.21% in the previous three months. Register for your complimentary reports on these five stocks at:
Q: 59.48 (+0.01), TMO: 126.79 (+0.13), A: 41.13 (-0.24), BRKR: 19.50 (+0.09), CVD: 103.73 (+0.02)
2014-2018 US Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers
M2 - Mon Dec 08, 8:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/mz6ptk/20142018_us) has announced the addition of the "2014-2018 US Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers" report to their offering. This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Company Profiles - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Decode - Diadexus - Eiken - Enzo - Exact Sciences - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Orchid CellMark - Ortho-Clinical Diagnostics - Proteome Sciences - Qiagen - Roche - Siemens - Sierra Molecular - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/mz...0142018_us
MYGN: 36.50 (+0.28), A: 41.13 (-0.24), DHR: 86.79 (-0.27)
Global Glycobiology/Glycomics Market 2014-2019: Enzymes, Instruments, Kits, and Reagents
M2 - Mon Dec 08, 3:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/sj4p7d/glycobiologyglyco) has announced the addition of the "Glycobiology/Glycomics Market by Product, Application & by End User - Global Forecast to 2019" report to their offering. The key drivers for this market are the rising R&D expenditure by pharmaceutical and biotech companies, and increasing public and private funding for proteomics and glycomics research. According to the World Bank, funding for research and development activities in Asia was about $158.94 billion in 2001 and increased to $329.31 billion in 2010. Similarly, in the U.S., overall funding for research and development was about $291.77 billion in 2001, which increased to $428.94 billion in 2010. Increased funding activities are expected to positively impact the growth of the glycomics enzymes, instruments, kits, and reagents market. This report segment the global glycomics market by application, end users, products, and geographies. The application segments included in this report are diagnostics; drug discovery and development; immunology; oncology; and other applications. The end-user segments of this market are academic research institutes, contract research organizations, and pharmaceutical and biotechnology companies. The product segments included in this report are enzymes; instruments; kits; and reagents. Glycosidases; glycosyltransferases; neuraminidases; sialyltransferases; and other enzymes are subsegments of the enzymes product segment. Antibody arrays; HPLC; lectin arrays; MALDI-TOF; mass spectrometers; and other glycomics instruments are subsegments of the instruments product segment. Glycan labeling kits; glycan purification kits; glycan release kits; and other glycomics kits are subsegments of the kits market. Glycoproteins; monosaccharaides; oligosaccharides; and other glycomics reagents are subsegments of the reagents product segment. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Glycomics Market, By Product 8 Glycomics Market, By Application 9 Glycomics Market, By End User 10 Geographic Analysis 11 Competitive Landscape 12 Company Profiles - Agilent Technologies, Inc. - Bruker Corporation - Danaher Corporation - New England Biolabs - Prozyme - Shimadzu Corporation - Sigma-Aldrich Corporation - Takara Bio - Thermo Fisher Scientific - Waters Corporation For more information visit http://www.researchandmarkets.com/research/sj...ologyglyco
A: 41.13 (-0.24), SIAL: 137.16 (-0.01), DHR: 86.79 (-0.27), WAT: 114.54 (+0.21)
My Conversation With Rye Patch Gold's Bill Howald
Ben Kramer-Miller - at Seeking Alpha - Sat Dec 06, 10:43AM CST
A: 41.13 (-0.24)
RNA Analysis/Transcriptomics Market - Global Forecast to 2019
M2 - Fri Dec 05, 3:48AM CST
Research and Markets (http://www.researchandmarkets.com/research/ftzhsm/rna) has announced the addition of the "RNA Analysis/Transcriptomics Market by Technology, by Application, by End-User - Global Forecast to 2019" report to their offering. The global transcriptomics market is expected to grow at a CAGR of 13.7% during the forecast period of 2014 to 2019 and is estimated to be worth $3,773.0 million by 2019. The transcriptomics market has blatantly grown in the past few years primarily due to the increasing technological advancements in the field of sequencing technologies in transcriptomics research. Similarly, the increasing government and private funding for research coupled with research and development investments by the biotechnology companies are expected to drive the transcriptomics market. The increasing adoption of transcriptomics in the field of biomarker discovery opens new growth avenues with the rising preference of personalized medicine across the globe. However, the higher investment costs that restrict the adoption of transcriptomics products and dearth of skilled professionals are the factors hampering the growth of this market to a certain extent. The transcriptomics market report covers the transcriptomic technologies, applications and end-users. The technologies market in this report is segmented as microarray, PCR, sequencing technologies which include Sanger sequencing and NGS, and RNAi gene silencing technology. Each of these technologies market is further sub-segmented into reagents, instruments and software. The applications of transcriptomics covered under the scope of this report are clinical diagnostics, drug discovery, and toxicogenomics. The end-users of transcriptomics are pharmaceutical and biotechnology companies, academic research and government institutes, and hospitals and diagnostic centers. This report also discusses the key market drivers, restraints, opportunities, challenges, and trends in the global transcriptomics market and its submarkets. The prominent players in the global trancriptomics market are Affymetrix Inc. (U.S.), Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), GE Healthcare (U.S.), Illumina Inc. (U.S.), Qiagen N.V. (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Sigma Aldrich (U.S.), Fluidigm Corporation (U.S.), and Thermofisher Scientific Inc. (U.S.). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Transcriptomics Technologies Market, By Type 8 Global Transcriptomics Market, By Application 9 Global Transcriptomics Market, By End User 10 Global Transcriptomics Market, By Geography 11 Company Profiles 12 Competitive Landscape 13 Appendix For more information visit http://www.researchandmarkets.com/research/ftzhsm/rna
FLDM: 32.31 (+0.30), A: 41.13 (-0.24), ILMN: 186.22 (+2.72), QGEN: 23.20 (+0.09), AFFX: 9.80 (+0.05)
Agilent Technologies and Baylor College of Medicine Open Center of Excellence in Mass Spectrometry
Business Wire - Thu Dec 04, 12:00PM CST
Agilent Technologies Inc. (NYSE: A) and Baylor College of Medicine, both known for their expertise in metabolomics, are working together to advance research and training in this vital branch of the life sciences.
A: 41.13 (-0.24)
Electronic Arts Inc. (EA) Rises: Stock Adds 5.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 04, 8:32AM CST
Electronic Arts Inc. (EA) was a big mover last session, as the company saw its shares rise more than 5% on the day.
ATVI: 20.35 (+0.12), JAKK: 6.81 (-0.27), A: 41.13 (-0.24)
InsiderInsights.com Daily Round Up 12/2/14: CINF, MDGN, AVID, NHF
InsiderInsights - at Seeking Alpha - Wed Dec 03, 6:11PM CST
BTF: 27.57 (+0.01), A: 41.13 (-0.24), MDGN: 5.19 (-0.02), NU: 55.02 (+1.27), BBY: 38.89 (-0.80), SPB: 97.15 (-0.49), MAR: 78.35 (-0.19), AVID: 14.36 (+0.26), CINF: 52.18 (-0.19), MPC: 88.62 (+0.24), NHF: 11.23 (+0.01), EPM: 7.49 (-0.01), EMC: 30.69 (+0.14), DNY: 22.38 (+0.47), MC: 35.26 (+0.09), TWI: 10.92 (-0.20), SFXE: 4.42 (+0.04), CSCO: 28.30 (+0.05)
Insider Trading Alert - ENTA, A And BHB Traded By Insiders
at The Street - Wed Dec 03, 9:08AM CST
Stocks with insider trader activity include ENTA, A and BHB
A: 41.13 (-0.24), BHB: 30.54 (-0.01), ENTA: 49.04 (+0.06)
Agilent Technologies (A) Upgraded From Hold to Buy
at The Street - Mon Dec 01, 7:58AM CST
Agilent Technologies (A) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B-.
A: 41.13 (-0.24)